A once-in-a-decade opportunity to buy these ASX 200 growth shares before they rocket?

Is now the time to seize on market weakness to buy these highly rated stocks?

| More on:
A group of people in suits watch as a man puts his hand up to take the opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think it is fair to say that the past few weeks have been difficult for investors. Particularly those that invest in ASX 200 growth shares.

The dramatic selloff has seen many shares retreating sharply from their recent highs.

While it is disappointing to see your portfolio shed value, every cloud has a silver lining.

The silver lining here is that it could have created a once-in-a-decade opportunity that investors have been waiting for – a chance to buy quality ASX 200 growth shares at a discount before they rebound and potentially rocket to new highs.

But which growth shares could be worth buying right now? Let's take a look at three that analysts are tipping as buys. They are as follows:

Lovisa Holdings Ltd (ASX: LOV)

The first ASX 200 growth share to consider buying after the selloff is Lovisa. This fashion jewellery retailer's shares have pulled back by over 7% from recent highs.

Analysts at Morgans will see this as a buying opportunity. Following a similar pullback at the end of last year, the broker commented: "Lovisa has proven it can successfully build out its unique brand in many diverse territories around the world on its journey to becoming a truly global brand. It's at times like these that investors should be getting set to reap the rewards of this strategy over the longer term."

Morgans has an add rating and $37.00 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX 200 growth share that was dragged lower during the market selloff is Pro Medicus. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

Analysts at Goldman Sachs are likely to see this pullback as a great opportunity for investors to buy this high quality company. Particularly given how the broker sees "PME as the clear incumbent technology leader in a growing market with a strong financial profile and significant AI upside."

It has a buy rating and $148.00 price target on its shares.

Xero Ltd (ASX: XRO)

A final stock that could be a top option for investors is Xero. This leading cloud-based accounting software provider is another ASX 200 growth share that has been caught up in the recent selloff.

However, despite the near-term volatility, Xero's long-term growth prospects remain very bright thanks to the structural shift to the cloud. In fact, Goldman Sachs estimates that it has a total addressable market of 100 million small to medium sized businesses. This compares to its current subscriber base of 4.2 million.

Goldman believes this gives it a multi-decade growth runway. It is no surprise then that it is tipping its shares as a buy with a $180.00 price target.

Motley Fool contributor James Mickleboro has positions in Lovisa, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Lovisa and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

two children squat down in the dirt with gardening tools and a watering can wearing denim overalls and smiling very sweetly.
Growth Shares

How to maximise $10,000 by investing in 2 ASX growth shares

Here are my best growth ideas on the ASX right now.

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

These ASX 200 growth shares could rise 50% to 60%

Big returns could be on offer from these growing companies according to analysts.

Read more »

Sports fans looking at smart phone representing surging pointsbet share price
Growth Shares

Up 111% in six months, this soaring ASX share is backed to keep rising

One fund manager thinks this ASX growth share can continue its phoenix performance.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

These ASX growth shares are being tipped to smash the market

Returns of 14% to 68% could be on the cards for buyers of these shares according to brokers.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Growth Shares

These ASX 200 growth shares could rise 50% to 70%

Analysts are predicting these stocks to rise materially from current levels.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

2 ASX 300 growth shares with 'strong momentum' this fund manager says are buys

These two stocks have plenty of growth potential, according to experts.

Read more »

Rocket going up above mountains, symbolising a record high.
Growth Shares

2 high-growth ASX shares to buy now

Analysts at Bell Potter think these shares would be great picks for growth investors.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth stocks could rise 30% to 100%

Analysts think these shares are dirt cheap at current levels and have put buy ratings on them.

Read more »